Neoadjuvant Chemoimmunotherapy
Neoadjuvant Chemoimmunotherapy is a therapeutic strategy that integrates chemotherapy and immunotherapy as a combined modality administered prior to definitive surgery or primary treatment to enhance antitumor immune responses and reduce tumor burden in the neoadjuvant setting.
235
Publications
13.9K
Citations
2.6K
Authors
733
Institutions
Publications per year
2017–2026
170
Parents
235
1–5 of 235
2.6K
Hospital Universitario Puerta de Hierro Majadahonda, Spain
10 publications · 381 citations
10
h-index
Hospital General Universitario de Alicante Doctor Balmis, Spain
8 publications · 357 citations
8
h-index
8
h-index
Hospital Universitario Insular de Gran Canaria, Spain
7 publications · 294 citations
7
h-index
7
h-index
1–5 of 2.6K
733
The University of Texas MD Anderson Cancer Center
Houston, United States
15 h-index
170 publications
49.9K citations
Union Hospital
Fuzhou, China
13 h-index
110 publications
4.2K citations
Hospital Universitario Puerta de Hierro Majadahonda
Madrid, Spain
11 h-index
57 publications
2.2K citations

Shanghai Chest Hospital
Shanghai, China
10 h-index
67 publications
1.7K citations

Shanghai Jiao Tong University
Shanghai, China
10 h-index
55 publications
1.2K citations

University Hospital Complex Of Vigo
Vigo, Spain
9 h-index
10 publications
495 citations

Sun Yat-sen University
Guangzhou, China
9 h-index
90 publications
4.7K citations

Central South University
Changsha, China
9 h-index
80 publications
2.6K citations
1–8 of 733
14 publications · 449 citations
12
h-index
11 publications · 426 citations
11
h-index
9 publications · 169 citations
8
h-index
Repository · 7 publications · 262 citations
7
h-index
7 publications · 246 citations
7
h-index
1–5